Key facts
- It has raised $30.9M; the latest was Later Stage VC in May 2025.
- Notable investors include CICC Capital, GF Xinde Investment Management, GF Qianhe, Baiyun Holding, Zhongke Kechuang.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for AKangHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for AKangHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AKangHealth
Developer of a pharmaceutical management platform designed to improve chronic disease care and prescription circulation. The company offers integrated drug management, hospital prescription distribution, e-commerce operations, and out-of-hospital prescription services, enabling patients with chronic conditions to access reliable medication and streamlined healthcare support.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2016
- Employees
- 1
- Ownership
- Privately Held (backing)
AKangHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AKangHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AKangHealth in its N-PORT filings yet. We sweep new filings monthly.